# Filing Detail

Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001104659-25-048564
Filing Date
2025-05-14
Accepted
2025-05-14 16:39:54
Documents
21

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 424B3 | tm256615-16_424b3.htm | 424B3 | 8212134
2 | GRAPHIC | lg_glycomimetics-4c.jpg | GRAPHIC | 33723
3 | GRAPHIC | lg_crescent-4clr.jpg | GRAPHIC | 13366
4 | GRAPHIC | bc_paidvstsr-4c.jpg | GRAPHIC | 34272
5 | GRAPHIC | bc_paidvsnetincome-4c.jpg | GRAPHIC | 34273
6 | GRAPHIC | bc_inhibitors-4c.jpg | GRAPHIC | 52077
7 | GRAPHIC | lc_nsclc-4clr.jpg | GRAPHIC | 78916
8 | GRAPHIC | tb_pfs-4c.jpg | GRAPHIC | 26172
9 | GRAPHIC | ph_vegf-4clr.jpg | GRAPHIC | 44251
10 | GRAPHIC | ph_cr001-4clr.jpg | GRAPHIC | 108813
11 | GRAPHIC | lc_cooperative-4c.jpg | GRAPHIC | 64616
12 | GRAPHIC | ph_antivegf-4c.jpg | GRAPHIC | 83797
13 | GRAPHIC | tb_clinicaldevelop-4c.jpg | GRAPHIC | 62088
14 | GRAPHIC | fc_chemotherapy-4clr.jpg | GRAPHIC | 96809
15 | GRAPHIC | fc_cr002adc-4c.jpg | GRAPHIC | 85532
16 | GRAPHIC | lg_lucidcapital-bwlr.jpg | GRAPHIC | 7806
17 | GRAPHIC | ft_lucidcapnewyork-bw.jpg | GRAPHIC | 6723
18 | GRAPHIC | sg_lucidcapitalmarkets-bw.jpg | GRAPHIC | 6380
19 | GRAPHIC | lg_walkers-bwlr.jpg | GRAPHIC | 4795
20 | GRAPHIC | px_glycoproxy1pg01-bw.jpg | GRAPHIC | 285436
21 | GRAPHIC | px_glycoproxy1pg02-bw.jpg | GRAPHIC | 234594
| Complete submission text file | 0001104659-25-048564.txt |  | 10051573

Mailing Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 240-243-1201
GLYCOMIMETICS INC (Filer) CIK: 0001253689 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-285035 | Film No.: 25946512
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)